Recent Company News

• 06:29 AM ET Feb 24, 2026
  

  Wolfe Research initiates ACAD, ALKS, AXSM, others

• 02:26 AM ET Feb 13, 2026
  

  Transcript Intelligence: Centessa Pharmaceuticals at Guggenheim Emerging Outlook Biotech Summit

• 03:35 AM ET Feb 12, 2026
  

  Centessa Pharmaceuticals to make $1.8M (¥275.3M) milestone payment to Nxera Pharma for ORX489 (¥876.0000, 0)

• 01:09 PM ET Jan 21, 2026
  

  StreetAccount Summary - US unusual volume traders

• 05:03 PM ET Jan 14, 2026
  

  Centessa pharmaceuticals announces poster presentation of new preclinical data supporting expansion of Orexin Receptor 2 (OX2R) agonist pipeline into neuropsychiatric indications at ACNP 2026 ($22.09, 0.00)

• 05:00 PM ET Jan 14, 2026
  

  Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting

• 06:35 PM ET Jan 12, 2026
  

  Nxera Pharma receives $3.6M (¥569.0M) milestone payment from Centessa (¥870.0000, 0)

• 10:08 PM ET Dec 12, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 05:09 PM ET Dec 11, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Dec 11, 2025
  

  StreetAccount Summary - US Pre-market trading update